Synthesis and evaluation of novel thiazolidinones from a long chain fatty acid 203
10. Gududuru V, Dalton T, Miller D. Discovery of 2-arylthiazolidine-4-
substitutions. e same correlation was found to be true
carboxylic acid amides as new class of cytotoxic agents for prostate
cancer. J Med Chem 2005;48:2584–2588.
11. Geronikaki AA, Lagunin AA, Hadjipablou-Litina DI, Eleftheriou
ET, Filimonov DA, Poroikov VV, Alam I, Saxena AA. Computer-
aided discovery of anti-inflammatory thiazolidinones with
in the case of the anti-inflammatory activity where the
presence of similar substituents at both these positions
(2 and 5) of the thiazolidinone ring led to anincreased
activity compared to the different substituents. However,
this correlation could not be observed in the analgesic
screening results where compound 6f, bearing chloro
and 4-hydroxy-3,5-dimethoxy groups, was found to be the
most active with 69.82 % inhibition of writhing. It was fol-
lowed by compounds 6e and 6g with 59.65 % inhibition.
dual cyclooxygenase/lipoxygenase inhibition.
2008;51:1601–1609.
J
Med Chem
12. Kumar A, Rajput CS, Bhati SK. Synthesis of 3-[4`-(p-chlorophenyl)-
thiazol-2`-yl]-2-[(substitutedazetidinone/thiazolidinone)-
aminoethyl]-6-bromoquinazoline-4-ones as anti-inflammatory agent.
Bioorg Med Chem 2007;15:3089–3096.
13. Hrib NJ, Jurcak JG, Bregna DE, Burgher KL, Hartman HB, Kafka S,
Kerman LL, Kongsamut S, Roehr JE, Szewczak MR, Woods-
Kettelberger AT, Corbett R. Structure-activity relationships of
a
series of novel (piperazinylbutyl)thiazolidinone antipsychotic
agents related to 3-[4-[4-(6-fluorobenzo[b]thien-3-yl)-1-piperazinyl]
Conclusion
butyl]-2,5,5-trimethyl-4-thiazolidinone maleate.
1996;39:4044–4057.
J Med Chem
In conclusion, the present investigation has described
the preparation of a series of novel thiazolidinones and
the evaluation of their potential for biological activities
such as anti-inflammatory, analgesic and hydrogen per-
oxide scavenging activity. e synthesised compounds
exhibited moderate anti-inflammatory and analgesic
activities in vivo and significant hydrogen peroxide scav-
enging activities in vitro.
14. Balzarini J, Orzeszko B, Maurin JK, Orzeszko A. Synthesis and anti-
HIV studies of 2-adamantyl-substituted thiazolidin-4-ones. Eur J Med
Chem 2007;42:993–1003.
15. Rawal RK, Kumar A, Siddiqi M, Kutti SB. Molecular docking
studies on 4-thiazolidinones as HIV-1 RT inhibitors. J Mol Model
2007;13:155–161.
16. Sonawane ND, Chatchai M, Ray NJR, Song Y, Verkman KS. In vivo
pharmacology and antidiarrheal efficacy of a thiazolidinone CFTR
inhibitors in rodents. J Pharm Sci 2005;94:134–143.
17. Kidwai M, Negi N, Mishra P. Microwave assisted synthesis of 2,3-
disubstituted 4-thiazolidinones and their pharmacological screening.
J Indian Chem Soc 2000;77:46–47.
18. Shih MH, Ke FY. Synthesis and evaluation of antioxidant activity of
sydnonyl substituted thiazolidinone and thiazoline derivatives. Bioorg
Med Chem 2004;12:4633–4643.
19. Kato T, Ozaki T, Ohi N. Novel calcium antagonists with both
calcium overload inhibition and antioxidant activity. 2. structure-
acknowledgement
Dr. Sandeep Jain, Assistant Professor, Department of
Pharmaceutical Sciences, Guru Jambheshwar University of
Science and Technology, Hisar-125001, India is duly acknowl-
edged for his valuable suggestions. Prof. Om Prakash, Director,
Institute of Pharmaceutical Sciences, Kurukshetra University,
Kurukshetra-136119, India, is duly acknowledged for providing
necessary facilities.
activity relationships of thiazolidinone Derivatives.
1999;42:3134–3146.
J Med Chem
20. Vagdevi HM, Vaidya VP, Latha KP, Padmashali B. Syntheis and
pharmacological examination of some thiazolidinone derivatives of
naptho[2,1-b]furan. Ind J Pharm Sci 2006;68:719–725.
21. Chaudhary SK, Verma M, Chaturvedi AK, Parmar SS. Substituted
thiazolidones: Selective inhibition of nicotinamide adenine
dinucleotide-dependent oxidations and evaluation of their cns activity.
J Pharm Sci 1974;64:614–617.
Declaration of interest
e authors report no conflicts of interest. e authors alone are
responsible for the content and writing of the paper.
22. Sharma A, Kumar V. 4-iazolidinone: A Pharmacologically Significant
st Rashtriya Yuva Vaigyanik Sammelan,
Nucleus. In: Proceeeding of the 1
2008:243–248.
23. Goel G, Arvidsson K, Vlaeminck B, Bruggeman G, Deschepper
K, Fievez V. Effects of capric acid on rumen methanogenesis and
biohydrogenation of linoleic and alpha-linolenic acid. Animal-e
Animal Consortium 2009;3:810–816.
references
1. Verma A, Saraf SK. 4-iazolidinone-a biologically active scaffold. Eur
J Med Chem 2008;43:897–905.
2. Havrylyuk D, Zimenkovsky B, Vasylenko O, Zaprutko L, Gzella A,
Lesyk R. Synthesis of novel thiazolone-based compounds containing
pyrazoline moiety and evaluation of their anticancer activity. Eur J Med
Chem 2009;44:1396–1404.
3. Ozkirimli S, Kazan F, Tunali Y. Synthesis, antibacterial and antifungal
activities of 3-(1,2,4-triazole-3-yl)-4-thiazolidinones. J Enzyme Inhib
Med Chem 2009;24:447–452.
4. Fuloria NK, Singh V, Shaharyar M, Ali M. Synthesis, characterization
and antimicrobial evaluation of novel imines and thiazolidinones. Acta
Pol Pharm 2009;66:141–146.
24. Marounek M, Skrivanova E, Rada V. Susceptibility of Escherichia coli to
C2-C fatty acids. Folia Microbiol 2003;48:731–735.
25. Kato18N. Antimicrobial activity of fatty acid and their esters against a
film-forming yeast in soysauce. J Food Safety 2007;3:121–126.
26. Carballeira NM, Ortiz D, Parang K, Sardari S. Total synthesis and in
vitro-antifungal activity of (+/-)-2-methoxytetradecanoic Acid. Archiv
Der Pharmazie 2004;337:152–155.
27. Chadeganipour M, Haims A. Antifungal activities of pelargonic and
capric acid on Microsporum gypseum. Mycoses 2001;44:109–112.
28. Liss A, Pefil JC, Levitt D. Cytotoxic and cytolytic activity of
nonadecafluoro-n-decanoic acid on Acholeplasma laidlawii. Appl
Environ Microbiol 1987;53:1236–1240.
29. Topical Antimicrobial Composition and Method, US Patent-5569461,
Issued on October 29, 1996, p. 1–3.
30. Molvi KI, Sudarsanam V, Patel MM, Haque N. Design, synthesis and
pharmacological evaluation of novel tetra substituted thiophene
analogs as anti-inflammatory agents. J Enzyme Inhib Med Chem
2008;23:819–828.
5. Shiradkar MR, Ghodake M, Bothara KG, Bhandari SV, Nikalje A, Akula
KC, Desai MC, Burange PJ. Synthesis and anticonvulsant activity
of clubbed thiazolidinone-barbituric acid thiazolidinone-triazole
derivatives. ARKIVOC 2007;(xiv):58–74.
6. Gursoy A, Terzioglu N. Synthesis and isolation of new regioisomeric
4-thiazolidinones and their anticonvulsant activity. Turk
2005;29:247–254.
J Chem
7. Srivastav T, Gaikwad AK, Haq W, Sinha S, Katti SB. Synthesis and
biological evaluation of 4-thiazolidinone derivatives as potential
antimycobacterial agents. ARKIVOK 2005;(ii):120–130.
8. Parekh HH, Parikh KA, Parikh AR. Synthesis of some 4-thiazolidinone
derivatives as antitubercular agents. J Sci IR Iran 2004;15:143–148.
9. Zhou H, Wu S, Zhai S, Liu A, Sun W, Li R, Zhang Y, Ekins S, Swaan
PW, Fang B, Zhang B, Yan B. Design, synthesis, cytoselective toxicity,
structure activity relationship, and pharmacophore of thiazolidinone
derivatives targeting drug resistant lung cancer cells. J Med Chem
2008;51:1242–1251.
31. Ottana R, Maccari R, Barreca ML, Bruno G, Rotondo A, Rossi A, Paola
RD, Sautebin L, Cuzzocrea S, Vigorita MG. 5-Arylidene-2-imino-4-
thiazolidinones: Design and synthesis of novel anti-inflammatory
agents. Bioorg Med Chem 2005;13:4243–4252.
32. Winter CA, Fisley EA, Nuss GW. Carrageenan induced oedema in the
hind paw of the rat as an assay for anti-inflammatory drugs. Proc Soc
Exp Biol Med 1962;111:544–547.
33. Gulcin I, Alici AH, Cesur M. Determination of in vitro antioxidant
and radical scavenging activities of propofol. Chem Pharm Bull
2005;53:281–285.
© 2011 Informa UK, Ltd.